Recurrent erysipelas: risk factors
Abstract
Patients with erysipelas, especially when it involves the lower limb, should be instructed to reduce weight, control venous insufficiency and/or lymphedema and to emphasize prevention and treatment of tinea pedis. The role of prophylactic antibiotics requires further study.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
male
adolescent
aged
middle aged
Child
Recurrence
risk factors
80 and over
Retrospective Studies
erysipelas / etiology*
hospitalization / statistics & numerical data
erysipelas / diagnosis
erysipelas / epidemiology
pmid:16279242
doi:10.1046/j.1439-0353.2004.03028.x
felix pavlotsky
shalom amrani
henry trau
leg dermatoses / diagnosis
leg dermatoses / etiology
Access
Citation
ID:
118275
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
118275
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet